Issue 1/2012
Content (25 Articles)
Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
Daniela Katz, Piyaporn Boonsirikamchai, Haeson Choi, Alexander J Lazar, Wei-Lein Wang, Lianchun Xiao, Min S Park, Vinod Ravi, Robert S Benjamin, Dejka M Araujo
An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma
Megan E Downing, Gillian S Dite, Mandy L Ballinger
The clinical use of biomarkers as prognostic factors in Ewing sarcoma
Annmeik M van Maldegem, Pancras CW Hogendoorn, Andrew B Hassan
Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH
Vincent PM Cliteur, Károly Szuhai, Hans J Baelde, Jurriaan van Dam, Hans Gelderblom, Pancras CW Hogendoorn
Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours
Fergal C Kelleher, David M Thomas
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis
Dagmar Berghuis, Marco W Schilham, Hanneke I Vos, Susy J Santos, Stephan Kloess, Emilie P Buddingh', R Maarten Egeler, Pancras CW Hogendoorn, Arjan C Lankester
Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
Annemiek M van Maldegem, Aparna Bhosale, Hans J Gelderblom, Pancras CW Hogendoorn, Andrew B Hassan
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans
Emanuela Palmerini, Marco Gambarotti, Eric L Staals, Licciana Zanella, Gabriela Sieberova, Alessandra Longhi, Marilena Cesari, Stefano Bonarelli, Piero Picci, Pietro Ruggieri, Marco Alberghini, Stefano Ferrari
Phenol levels during intralesional curettage and local adjuvant treatment of benign and low-grade malignant bone tumours
Suzan HM Verdegaal, Jan den Hartigh, Pancras CW Hogendoorn, Hugo FG Brouwers, Antonie HM Taminiau
Serum tumor markers in pediatric osteosarcoma: a summary review
Yulia A Savitskaya, Genaro Rico-Martínez, Luis Miguel Linares-González, Ernesto Andrés Delgado-Cedillo, René Téllez-Gastelum, Alfonso Benito Alfaro-Rodríguez, Antonio Redón-Tavera, José Clemente Ibarra-Ponce de León
Hereditary and environmental epidemiology of sarcomas
David M Thomas, Sharon A Savage, Gareth L Bond
Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications
Michael A Postow, Mark E Robson
Sarcomas in hereditary retinoblastoma
Ruth A Kleinerman, Sara J Schonfeld, Margaret A Tucker
Malignant peripheral nerve sheath tumours in inherited disease
D Gareth R Evans, Susan M Huson, Jillian M Birch
Mouse models of sarcomas: critical tools in our understanding of the pathobiology
Sean M Post
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
Florence Duffaud, Caroline Even, Isabelle Ray-Coquard, Emmanuelle Bompas, Thanh Khoa-Huynh, Sebastien Salas, Philippe Cassier, Armelle Dufresne, Sylvie Bonvalot, Francoise Ducimetiere, Axel Le Cesne, Jean-Yves Blay
Sarcoma risk after radiation exposure
Amy Berrington de Gonzalez, Alina Kutsenko, Preetha Rajaraman
The rule of fives, a simple way to stratify risk for primary gastrointestinal stromal tumors (GIST)
Robert G Maki
Genetically engineered mouse models and human osteosarcoma
Alvin JM Ng, Anthony J Mutsaers, Emma K Baker, Carl R Walkley
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib
Silvia Stacchiotti, Gian Paolo Dagrada, Carlo Morosi, Tiziana Negri, Antonella Romanini, Silvana Pilotti, Alessandro Gronchi, Paolo G Casali
Management of imatinib-associated skin rash in a patient with metastatic gastrointestinal stromal tumor: a case report
Jean-Yves Blay
The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease
Dagmar Berghuis, Marco W Schilham, Susy J Santos, Suvi Savola, Helen J Knowles, Uta Dirksen, Karl-Ludwig Schaefer, Jukka Vakkila, Pancras CW Hogendoorn, Arjan C Lankester
The Epidemiology of Sarcoma
Zachary Burningham, Mia Hashibe, Logan Spector, Joshua D Schiffman
Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing’s and other Small Round Cell Sarcomas
Jeremy Whelan, Atia Khan, Anand Sharma, Christian Rothermundt, Palma Dileo, Maria Michelagnoli, Beatrice Seddon, Sandra Strausss
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien Wang, Daniela Katz, Dejka M Araujo, Vinod Ravi, Joseph A Ludwig, Jonathan C Trent, Shreyaskumar R Patel, Patrick P Lin, Ashleigh Guadagnolo, Dolores Lòpez-Terrada, Angelo Paola dei Tos, Valerie O Lewis, Dina Lev, Raphael E Pollock, Gunar K Zagars, Robert S Benjamin, John E Madewell, Alexander J Lazar